JP2009537507A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537507A5
JP2009537507A5 JP2009510567A JP2009510567A JP2009537507A5 JP 2009537507 A5 JP2009537507 A5 JP 2009537507A5 JP 2009510567 A JP2009510567 A JP 2009510567A JP 2009510567 A JP2009510567 A JP 2009510567A JP 2009537507 A5 JP2009537507 A5 JP 2009537507A5
Authority
JP
Japan
Prior art keywords
use according
mammal
atherosclerosis
disease
related disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009510567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537507A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/001264 external-priority patent/WO2007132338A2/en
Publication of JP2009537507A publication Critical patent/JP2009537507A/ja
Publication of JP2009537507A5 publication Critical patent/JP2009537507A5/ja
Pending legal-status Critical Current

Links

JP2009510567A 2006-05-15 2007-05-15 アテローム性動脈硬化症に対して保護的な自己抗体を誘導するＩＬ−１α免疫法 Pending JP2009537507A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80002906P 2006-05-15 2006-05-15
PCT/IB2007/001264 WO2007132338A2 (en) 2006-05-15 2007-05-15 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS

Publications (2)

Publication Number Publication Date
JP2009537507A JP2009537507A (ja) 2009-10-29
JP2009537507A5 true JP2009537507A5 (enExample) 2010-07-01

Family

ID=38694276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009510567A Pending JP2009537507A (ja) 2006-05-15 2007-05-15 アテローム性動脈硬化症に対して保護的な自己抗体を誘導するＩＬ−１α免疫法

Country Status (9)

Country Link
US (1) US20090191149A1 (enExample)
EP (1) EP2021033B1 (enExample)
JP (1) JP2009537507A (enExample)
CN (1) CN101448528A (enExample)
AT (1) ATE551365T1 (enExample)
AU (1) AU2007251239B2 (enExample)
CA (1) CA2652274A1 (enExample)
ES (1) ES2384278T3 (enExample)
WO (1) WO2007132338A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109187944A (zh) * 2005-08-02 2019-01-11 埃克斯生物科技公司 使用IL-1α自身抗体诊断、治疗和预防血管疾病
US20110008282A1 (en) * 2006-05-15 2011-01-13 Xbiotech, Inc. IL-1alpha immunization induces autoantibodies protective against atherosclerosis
PT2109623E (pt) * 2006-05-22 2012-01-12 Xbiotech Inc Tratamento de cancro com anticorpos anti-il-1
CN105467136B (zh) 2008-05-30 2018-02-16 埃克斯生物科技公司 白细胞介素‑1α抗体及使用方法
WO2010030979A2 (en) 2008-09-12 2010-03-18 Xbiotech, Inc. Targeting pathogenic monocytes
EP2569640A1 (en) 2010-05-12 2013-03-20 The University of Birmingham Biomarker
JP6324720B2 (ja) 2010-06-18 2018-05-16 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 関節炎治療
KR102748255B1 (ko) 2010-08-23 2024-12-31 엑스바이오테크 인코포레이티드 종양성 질병들에 대한 치료
US9724409B2 (en) 2011-04-01 2017-08-08 Xbiotech, Inc. Treatment of inflammatory skin disease
JP6204915B2 (ja) 2011-09-23 2017-09-27 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 悪液質治療
US9545441B2 (en) 2012-09-18 2017-01-17 Xbiotech, Inc. Treatment of diabetes
JP6456015B2 (ja) * 2013-07-19 2019-01-23 国立大学法人三重大学 閉塞性動脈硬化症モデル動物、るい痩研究用モデル動物、及び全身性アミロイドーシスモデル動物としての非ヒト哺乳動物
CN105175503A (zh) * 2015-09-08 2015-12-23 苏州普罗达生物科技有限公司 因子viii抑制多肽及其应用
CN105175504A (zh) * 2015-09-08 2015-12-23 苏州普罗达生物科技有限公司 血管性血友病因子抑制多肽及其应用
KR20190117579A (ko) 2017-02-16 2019-10-16 엑스바이오테크, 인크. 화농성 한선염의 치료
US10975146B2 (en) 2018-06-29 2021-04-13 Cedars-Sinai Medical Center Interleukin-1 inhibition for combination treatment of pancreatic cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802402D0 (sv) * 1998-07-03 1998-07-03 Karolinska Innovations Ab Method of diagnosing cardiovascular disease and early atherosclerosis
US6555579B2 (en) * 1998-08-13 2003-04-29 The Wistar Institute Methods for reducing atherosclerotic plaques
US20030040617A9 (en) * 1999-03-12 2003-02-27 Rosen Craig A. Nucleic acids, proteins and antibodies
US20030232054A1 (en) * 2000-01-25 2003-12-18 Tang Y. Tom Novel nucleic acids and polypeptides
US20030026806A1 (en) * 2000-10-27 2003-02-06 Amgen Inc. Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof
WO2004100987A2 (en) * 2003-05-06 2004-11-25 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to treat neointimal hyperplasia
HN2004000285A (es) * 2003-08-04 2006-04-27 Pfizer Prod Inc ANTICUERPOS DIRIGIDOS A c-MET
CN109187944A (zh) * 2005-08-02 2019-01-11 埃克斯生物科技公司 使用IL-1α自身抗体诊断、治疗和预防血管疾病
KR20080047564A (ko) * 2005-09-28 2008-05-29 사이토스 바이오테크놀로지 아게 인터루킨-1 컨쥬게이트 및 그의 용도
CN105467136B (zh) * 2008-05-30 2018-02-16 埃克斯生物科技公司 白细胞介素‑1α抗体及使用方法
WO2010030979A2 (en) * 2008-09-12 2010-03-18 Xbiotech, Inc. Targeting pathogenic monocytes

Similar Documents

Publication Publication Date Title
JP2009537507A5 (enExample)
JP2009544279A5 (enExample)
JP2012505837A5 (enExample)
WO2008076915A8 (en) Treatment of pigs with pcv2 antigen
RU2015149387A (ru) Способы применения интерлейкина-10 для лечения заболеваний и расстройств
SMT201300095B (it) Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
ECSP11011173A (es) Agentes inductores de apoptosis para el tratamiento de cancer y enfermedades inmunes y autoinmunes
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
JP2016516074A5 (enExample)
EP2665479A4 (en) METHOD AND MEDICAMENT PRODUCTS FOR THE TREATMENT OF MORBUS ALZHEIMER
EA200801427A1 (ru) Молекулы антитела со специфической активностью в отношении интерлейкина-6 (ил-6) человека
WO2005007652A3 (en) Substituted quinolin-4-ylamine analogues
JP6640725B2 (ja) ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す
JP2013510169A5 (enExample)
JP2014508164A5 (enExample)
WO2009099642A3 (en) Proteomic analysis of active multiple sclerosis lesions
EP2528931A4 (en) CYCLOVIRUS AND USE METHOD THEREFOR
BRPI0508434A (pt) usos de 1-aminociclohexano para o tratamento de distúrbios comportamentais associados ao mal de alzheimer
EA200900330A1 (ru) Аналоги 2-феноксипиримидинона
WO2006026135A3 (en) Substituted biaryl piperazinyl-pyridine analogues
RU2009128218A (ru) Новый аллерген-простатический калликреин
JP2007531510A5 (enExample)
ATE470151T1 (de) Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern
de Jaham Effects of an ethyl lactate shampoo in conjunction with a systemic antibiotic in the treatment of canine superficial bacterial pyoderma in an open-label, nonplacebo-controlled study.